New aspects of staphylococcal infections: emergence of coagulase-negative staphylococci as pathogens
- PMID: 6397138
- DOI: 10.1007/BF02386237
New aspects of staphylococcal infections: emergence of coagulase-negative staphylococci as pathogens
Abstract
In contrast to the well-established pathogen Staphylococcus aureus, the coagulase-negative staphylococci, formerly collectively called S. epidermidis, were until recently regarded as harmless commensals. During the last two decades, however, the coagulase-negative staphylococci have clearly emerged as pathogens in patients carrying artificial devices, such as prosthetic heart valves, hip prostheses and cerebrospinal fluid shunts, and in patients with compromised host defenses such as premature neonates and cancer and transplant patients. The present paper reviews current insights on classification, bacteriology, pathogenic potential and virulence factors of coagulase-negative staphylococci. In addition, the role of host defense factors in resistance to staphylococcal infection is summarized as well as the main features of the clinical syndromes in which coagulase-negative staphylococci are involved.
Similar articles
-
Coagulase-negative staphylococci as nosocomial pathogens in neonates. The role of host defense, artificial devices, and bacterial hydrophobicity.Am J Med. 1986 Jun 30;80(6B):161-5. doi: 10.1016/0002-9343(86)90495-x. Am J Med. 1986. PMID: 3728527
-
Coagulase-negative staphylococci: role as pathogens.Annu Rev Med. 1999;50:223-36. doi: 10.1146/annurev.med.50.1.223. Annu Rev Med. 1999. PMID: 10073274 Review.
-
Coagulase-negative staphylococci. Pathogens have major role in nosocomial infections.Postgrad Med. 2001 Oct;110(4):63-4, 69-70, 73-6. Postgrad Med. 2001. PMID: 11675983 Review.
-
The role of typing of coagulase-negative staphylococci in hospital-acquired infection.J Hosp Infect. 1984 Dec;5 Suppl A:51-5. doi: 10.1016/0195-6701(84)90030-6. J Hosp Infect. 1984. PMID: 6084685
-
Neonatal immune responses to coagulase-negative staphylococci.Curr Opin Infect Dis. 2007 Aug;20(4):370-5. doi: 10.1097/QCO.0b013e3281a7ec98. Curr Opin Infect Dis. 2007. PMID: 17609595 Review.
Cited by
-
Antiphagocytic effect of the capsule of Staphylococcus simulans.Infect Immun. 1990 May;58(5):1350-4. doi: 10.1128/iai.58.5.1350-1354.1990. Infect Immun. 1990. PMID: 2323819 Free PMC article.
-
Staphylococcus epidermidis and its dual lifestyle in skin health and infection.Nat Rev Microbiol. 2023 Feb;21(2):97-111. doi: 10.1038/s41579-022-00780-3. Epub 2022 Aug 30. Nat Rev Microbiol. 2023. PMID: 36042296 Free PMC article. Review.
-
Development of real-time in vivo imaging of device-related Staphylococcus epidermidis infection in mice and influence of animal immune status on susceptibility to infection.J Infect Dis. 2008 Jul 15;198(2):258-61. doi: 10.1086/589307. J Infect Dis. 2008. PMID: 18491976 Free PMC article.
-
Prevalence and antimicrobial resistance of coagulase negative staphylococci clinical isolates from Ethiopia: a meta-analysis.BMC Microbiol. 2018 May 25;18(1):43. doi: 10.1186/s12866-018-1188-6. BMC Microbiol. 2018. PMID: 29801462 Free PMC article.
-
Pathogenicity and virulence of coagulase negative staphylococci in relation to adherence, hydrophobicity, and toxin production in vitro.J Clin Pathol. 1994 Aug;47(8):743-8. doi: 10.1136/jcp.47.8.743. J Clin Pathol. 1994. PMID: 7962630 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical